Morinaga Milks Probiotic Bifidobacterium breve B3 Receives Approval of Individual Recognized Registration in South Korea

Morinaga Milk Industry Co. Ltd. TOKYO2264 a leading Japanese dairy product company today announced its proprietary probiotic strainBifidobacterium breve B3 has received the approval of Individual Recognized Registration in South Korea for its clinically demonstrated efficacy in body fat reduction.

Related Keywords

Japan ,South Korea ,Tokyo ,Japanese ,Mitsunori Watanabe Kazuaki Kajikawa ,Yoshihiko Ushida ,Junichi Minami Chyn ,B Business Department Of Morinaga ,Morinaga Milk Group ,International Division ,Health Functional Foods ,Morinaga Milk Industry Co Ltd ,Health Functional Food Deliberation Committee ,Investor Public Relations Department ,Individual Recognized Registration ,Business Wire ,Drug Safety ,Human Residential Bifidobacteria ,Help Reduce Body ,Individual Recognized ,Morinaga Milk ,General Manager ,Year Vision ,Morinaga Human Residential Bifidobacteria ,Media Contact ,Public Relations Department ,Kazuaki Kajikawa ,Chyn Boon Wong ,Morinaga Milk Industry Co Ltd Bifidobacterium Breve B3 Efficacy Japanese Dairy Product Company Body Fat Reduction Clinically Demonstrated 5 Billion Cfu Per Day Humanresidential Bifidobacteria Hrbprobiotic Strain Gut Microbiota Metabolic Syndrome Aiding Highquality Regulation Health Functional Food Deliberation Committee ,